7.43
17.75%
1.12
アフターアワーズ:
7.45
0.02
+0.27%
Nuvectis Pharma Inc (NVCT) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Research and Development |
37.63%
2.66
|
4.265 | 4.486 | 4.262 | 2.367 |
Operating Income/Loss |
35.97%
-4.396
|
-6.866 | -6.158 | -5.772 | -4.101 |
Income/Loss From Continuing Operations Before Tax |
37.01%
-4.171
|
-6.622 | -5.881 | -5.708 | -4.049 |
Income/Loss From Continuing Operations After Tax |
37.01%
-4.171
|
-6.622 | -5.881 | -5.708 | -4.049 |
Net Income/Loss
|
37.01%
-4.171
|
-6.622 | -5.881 | -5.708 | -4.049 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
7,603%
16.56
|
0.215 | 16.10 | 15.18 | 14.72 |
Diluted Average Shares |
7,603%
16.56
|
0.215 | 16.10 | 15.18 | 14.72 |
Basic Earnings Per Share |
39.02%
-0.25
|
-0.41 | -0.37 | -0.38 | -0.27 |
Diluted Earnings Per Share |
39.02%
-0.25
|
-0.41 | -0.37 | -0.38 | -0.27 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):